Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota
Abstract Background Huanglian Jiedu Decoction (HLJDD) is a representative formula for clearing heat and removing toxins, and some basic studies indicated that it can improve the learning cognitive ability of Alzheimer’s disease (AD) mice, but the underlying molecular mechanism of its improvement in...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Chinese Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-025-01180-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849761247241699328 |
|---|---|
| author | Yani Zhang Jiahua Wang Xuetao Li Ruibo Guo Liyan Wang Yang Liu Yang Yu Liang Kong |
| author_facet | Yani Zhang Jiahua Wang Xuetao Li Ruibo Guo Liyan Wang Yang Liu Yang Yu Liang Kong |
| author_sort | Yani Zhang |
| collection | DOAJ |
| description | Abstract Background Huanglian Jiedu Decoction (HLJDD) is a representative formula for clearing heat and removing toxins, and some basic studies indicated that it can improve the learning cognitive ability of Alzheimer’s disease (AD) mice, but the underlying molecular mechanism of its improvement in AD mice is still unclear, therefore, this paper delves into the mechanism of HLJDD to improve AD. Purpose This study aims to investigate whether HLJDD can improve the “central-peripheral” inflammatory microenvironment in APP/PS1 mice, and to explore its relationship with gut microbiota and NLRP3 inflammatory vesicles activation. Materials and methods In this paper, the fingerprint of HLJDD was established by high-performance liquid chromatography (HPLC) and the components of HLJDD were characterized by ultra-performance liquid chromatography-time-of-flight mass spectrometry (UPLC-O-TOF/MS). The potential signaling pathways of HLJDD against AD were preliminarily investigated through network pharmacology. Behavioral assessment, histopathological staining, immunofluorescence staining, immunohistochemical staining, and detection of central and peripheral inflammatory factors were used to explore the improvement of AD by HLJDD, in addition to which we examined the gut microbiota and expression of relevant inflammatory proteins. Results In this study, 137 chemical constituents, including flavonoids, terpenoids, and alkaloids, were first identified in HLJDD by HPLC fingerprinting and UPLC-Q-TOF/MS. In addition, 49 components were found in the brain tissue of APP/PS1 mice and 48 components were found in the plasma of APP/PS1 mice. Network pharmacology concluded that the relevant pathways for HLJDD treatment of AD include inflammatory pathways. We found that HLJDD was effective in improving the learning memory ability of APP/PS1 mice by in vivo mouse behavioral performance. Histopathological results showed that HLJDD had the effect of reducing AD-like pathological damage, and also found that HLJDD could significantly reduce the proportion of M1 type microglia and A1 type astrocytes, and increase the proportion of M2 type microglia and A2 type astrocytes, and the treatment of HLJDD also suppressed the infiltration of CD4+ and CD8+ T-cells in the brain, and inhibited Aβ deposition and reduced the expression of inflammatory factors in the brain, and alleviated central neuroinflammation. In addition, it was also found that HLJDD was able to reduce the expression of inflammatory factors in the peripheral blood and inhibit the peripheral immune response, and the results of gut microbiota also showed changes in gut microbiota after HLJDD treatment and verified the expression of inflammatory vesicle-associated proteins in the intestines, with significant upregulation of the expression of NLRP3, caspase-1, and ASC proteins in the model group, and significant downregulation of ZO-1 and occludin proteins, and reversal of the above changes after HLJDD intervention. Conclusion Therefore, it is hypothesized that HLJDD improves the “central-peripheral” inflammatory microenvironment in APP/PS1 mice by inhibiting the activation of NLRP3 inflammatory vesicles mediated by gut microbiota. |
| format | Article |
| id | doaj-art-4e9cae0bc1bb4cb391d51412f5055116 |
| institution | DOAJ |
| issn | 1749-8546 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Chinese Medicine |
| spelling | doaj-art-4e9cae0bc1bb4cb391d51412f50551162025-08-20T03:06:05ZengBMCChinese Medicine1749-85462025-08-0120111810.1186/s13020-025-01180-4Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiotaYani Zhang0Jiahua Wang1Xuetao Li2Ruibo Guo3Liyan Wang4Yang Liu5Yang Yu6Liang Kong7College of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineCollege of Pharmacy, Liaoning University of Traditional Chinese MedicineAbstract Background Huanglian Jiedu Decoction (HLJDD) is a representative formula for clearing heat and removing toxins, and some basic studies indicated that it can improve the learning cognitive ability of Alzheimer’s disease (AD) mice, but the underlying molecular mechanism of its improvement in AD mice is still unclear, therefore, this paper delves into the mechanism of HLJDD to improve AD. Purpose This study aims to investigate whether HLJDD can improve the “central-peripheral” inflammatory microenvironment in APP/PS1 mice, and to explore its relationship with gut microbiota and NLRP3 inflammatory vesicles activation. Materials and methods In this paper, the fingerprint of HLJDD was established by high-performance liquid chromatography (HPLC) and the components of HLJDD were characterized by ultra-performance liquid chromatography-time-of-flight mass spectrometry (UPLC-O-TOF/MS). The potential signaling pathways of HLJDD against AD were preliminarily investigated through network pharmacology. Behavioral assessment, histopathological staining, immunofluorescence staining, immunohistochemical staining, and detection of central and peripheral inflammatory factors were used to explore the improvement of AD by HLJDD, in addition to which we examined the gut microbiota and expression of relevant inflammatory proteins. Results In this study, 137 chemical constituents, including flavonoids, terpenoids, and alkaloids, were first identified in HLJDD by HPLC fingerprinting and UPLC-Q-TOF/MS. In addition, 49 components were found in the brain tissue of APP/PS1 mice and 48 components were found in the plasma of APP/PS1 mice. Network pharmacology concluded that the relevant pathways for HLJDD treatment of AD include inflammatory pathways. We found that HLJDD was effective in improving the learning memory ability of APP/PS1 mice by in vivo mouse behavioral performance. Histopathological results showed that HLJDD had the effect of reducing AD-like pathological damage, and also found that HLJDD could significantly reduce the proportion of M1 type microglia and A1 type astrocytes, and increase the proportion of M2 type microglia and A2 type astrocytes, and the treatment of HLJDD also suppressed the infiltration of CD4+ and CD8+ T-cells in the brain, and inhibited Aβ deposition and reduced the expression of inflammatory factors in the brain, and alleviated central neuroinflammation. In addition, it was also found that HLJDD was able to reduce the expression of inflammatory factors in the peripheral blood and inhibit the peripheral immune response, and the results of gut microbiota also showed changes in gut microbiota after HLJDD treatment and verified the expression of inflammatory vesicle-associated proteins in the intestines, with significant upregulation of the expression of NLRP3, caspase-1, and ASC proteins in the model group, and significant downregulation of ZO-1 and occludin proteins, and reversal of the above changes after HLJDD intervention. Conclusion Therefore, it is hypothesized that HLJDD improves the “central-peripheral” inflammatory microenvironment in APP/PS1 mice by inhibiting the activation of NLRP3 inflammatory vesicles mediated by gut microbiota.https://doi.org/10.1186/s13020-025-01180-4Huanglian Jiedu DecoctionAlzheimer’s diseaseGut microbiotaNLRP3 |
| spellingShingle | Yani Zhang Jiahua Wang Xuetao Li Ruibo Guo Liyan Wang Yang Liu Yang Yu Liang Kong Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota Chinese Medicine Huanglian Jiedu Decoction Alzheimer’s disease Gut microbiota NLRP3 |
| title | Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota |
| title_full | Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota |
| title_fullStr | Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota |
| title_full_unstemmed | Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota |
| title_short | Huanglian Jiedu Decoction improves the"central-peripheral"inflammatory microenvironment and enhances the cognitive function of APP/PS1 mice by inhibiting the activation of NLRP3 inflammasome mediated by gut microbiota |
| title_sort | huanglian jiedu decoction improves the central peripheral inflammatory microenvironment and enhances the cognitive function of app ps1 mice by inhibiting the activation of nlrp3 inflammasome mediated by gut microbiota |
| topic | Huanglian Jiedu Decoction Alzheimer’s disease Gut microbiota NLRP3 |
| url | https://doi.org/10.1186/s13020-025-01180-4 |
| work_keys_str_mv | AT yanizhang huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT jiahuawang huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT xuetaoli huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT ruiboguo huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT liyanwang huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT yangliu huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT yangyu huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota AT liangkong huanglianjiedudecoctionimprovesthecentralperipheralinflammatorymicroenvironmentandenhancesthecognitivefunctionofappps1micebyinhibitingtheactivationofnlrp3inflammasomemediatedbygutmicrobiota |